ANTs SyN Normalization with Brain Tumor Lesions: Patient-to-MNI (Moving Mask) vs. MNI-to-Patient (Fixed Mask)? #1927
Unanswered
cxstevenddd
asked this question in
Q&A
Replies: 1 comment 3 replies
-
|
The mask specifies where the similarity metric and gradient is calculated so you'd need to invert the tumor mask. Also, you'd have to go with Option 2 as one can specify just a fixed mask, both a fixed mask and a moving mask, but not just a moving mask. |
Beta Was this translation helpful? Give feedback.
3 replies
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
Uh oh!
There was an error while loading. Please reload this page.
-
I am working on a pipeline for the Lesion Quantification Toolkit (LQT) and need to normalize Brain Tumor patient T1 images (with tumors) to MNI space. I plan to use ANTs SyN with Cost Function Masking. My core question is about the direction of registration and how the mask is handled during optimization: Option 1: Patient (Moving) to MNI (Fixed). I would input the tumor lesion mask as a "Moving Mask" to exclude the lesion from the metric. Option 2: MNI (Moving) to Patient (Fixed). I would input the tumor lesion mask as a "Fixed Mask," and then apply the calculated inverse warp to the patient image/mask later. Intuitively, Option 2 seems safer because the patient image serves as the fixed domain, ensuring the tumor lesion mask remains static and perfectly aligned with the anatomy throughout the optimization process. I am concerned that in Option 1, as the patient image deforms iteratively, the "Moving Mask" might not deform perfectly in sync, potentially failing to mask the lesion artifacts effectively. Is my concern about the "Moving Mask" valid? Does ANTs handle robust resampling of moving masks across iterations, or is the "Fixed Patient + Inverse Warp" strategy generally preferred for brain tumor lesion normalization?
Beta Was this translation helpful? Give feedback.
All reactions